Skip to main content
Clinical Trials/ACTRN12617000550303
ACTRN12617000550303
Completed
未知

In patients with Osteoarthritis of the hip undergoing a Total Hip Replacement, how does the MASTER-SL femoral stem perform under standard conditions with regards to clinical outcomes.

The Orthopaedic Institute of Queensland (ORIQL)0 sites50 target enrollmentApril 19, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
The Orthopaedic Institute of Queensland (ORIQL)
Enrollment
50
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 19, 2017
End Date
October 30, 2017
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
The Orthopaedic Institute of Queensland (ORIQL)

Eligibility Criteria

Inclusion Criteria

  • Male and female \>18 years;
  • radiologically confirmed diagnosis of primary osteoarthritis (OS) of the hip and suitable for primary total hip replacement;
  • Life expectancy of \> 10 years
  • Receiving a MASTER\-SL femoral stem
  • Voluntary written informed consent obtained

Exclusion Criteria

  • Prospect for recovery to independent mobility compromised by known coexistent, medical problems;
  • Requiring revision hip replacement;
  • Loss of abductor musculature, poor bone stock, or poor skin coverage around the hip join;
  • Previous organ transplant;
  • Previous hip replacement (resurfacing or THR) on the contra\-lateral side within the last 6 months;
  • Previous hip replacement (resurfacing or THR) on the contralateral side and whose outcome is achieving an Oxford Hip score \<18 points;
  • Body mass index \> 40 kg/m2
  • Active or suspected infection;
  • Known sensitivity to device materials;
  • Pregnant woman

Outcomes

Primary Outcomes

Not specified

Similar Trials